Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
A fresh analyst update on Coca-Cola did not move its price target, suggesting expectations tied to the company’s valuation framework remain broadly unchanged. Even so, the commentary highlights where new information could matter for how investors read the beverage maker’s outlook.
THE APEX TIMES
THE APEX TIMES
Hospitals allege CVS subsidiaries improperly kept roughly $250 million in 340B-related savings from 2020 to 2025. At the same time, CVS Caremark is positioning GLP-1 weight-management products as a key growth area for 2026.
THE APEX TIMES
On June 5, Coinbase (COIN) fell about 9% in the afternoon session after Baird cut its price target and warned that lower trading activity could delay a near-term revenue rebound.
THE APEX TIMES
A new market analysis from Yahoo Finance revisits the question of where investors should look once Nvidia is already the default pick for AI compute. The comparison centers on AMD and Broadcom, with the writer arguing that one stands out for the next leg of the market.
THE APEX TIMES
Raytheon and Northrop Grumman say they have moved to phase two of DARPA’s Burn n’ Go program, targeting a “composable” solid rocket motor that can adjust thrust after manufacturing.
THE APEX TIMES
The company says copper theft and vandalism are increasingly disrupting parts of its legacy infrastructure, and it is pairing tougher enforcement with ongoing plans to move customers off copper and onto fiber.
THE APEX TIMES
A fiscal quarter that topped expectations and an upward revision to full-year operating income guidance helped bring Tyson Foods back into focus, as Goldman Sachs reportedly added the company to its conviction list. Investors will now look for follow-through on margins and cash generation.
THE APEX TIMES
A new market commentary argues Nvidia may be carving out another large opportunity, intensifying pressure on AMD and Intel as competition in accelerated computing stays fierce.
THE APEX TIMES
Shares of UnitedHealth Group climbed to close at $399.47, prompting a fresh round of debate about what the company’s earnings and business outlook justify in the current market.
